Loading…

Monoclonal IgM from patients with peripheral demyelinating neuropathies cross‐react with bacterial polypeptides

SUMMARY Human monoclonal IgM associated with a demyelinating peripheral neuropathy often feature a distinct antibody activity directed against a glucuronyl sulphate epitope shared by myelin‐associated glycoprotein (MAG), nerve glycolipids and low molecular weight peripheral nerve polypeptides‐ Earli...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental immunology 1994-06, Vol.96 (3), p.466-469
Main Authors: BROUET, J.‐C., MARIETTE, X., GENDRON, M.‐C., DUBREUIL, M.‐L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SUMMARY Human monoclonal IgM associated with a demyelinating peripheral neuropathy often feature a distinct antibody activity directed against a glucuronyl sulphate epitope shared by myelin‐associated glycoprotein (MAG), nerve glycolipids and low molecular weight peripheral nerve polypeptides‐ Earlier studies showed that these IgM use a diverse repertoire of VH, and VL genes which exhibit somatic mutations, possibly indicative of an antigen‐driven process. Here, we investigated whether such monoclonal IgM may react with environmental bacterial antigens. We found that six patients' sera and purified monoclonal IgM, as well as IgM from supernatants of three clonal anti‐MAG‐secreting cell lines reacted with unique 90 ‐100kD polypeptides from extracts of two out of 10 bacterial species. Purified MAG was able to inhibit this reactivity. These results indicate molecular mimicry as a possible mechanism of this immunomediated neuropathy and associated clonal lymphoid disease.
ISSN:0009-9104
1365-2249
DOI:10.1111/j.1365-2249.1994.tb06052.x